CAS 138071-82-6: Gadobutrol

Description: Gadobutrol is a gadolinium-based contrast agent primarily used in magnetic resonance imaging (MRI) to enhance the visibility of internal structures. It is a paramagnetic compound, which means it has unpaired electrons that enhance the magnetic properties of tissues during imaging. Gadobutrol is characterized by its high relaxivity, allowing for improved contrast in MRI scans. It is a non-ionic, water-soluble compound, which contributes to its safety profile and minimizes the risk of adverse reactions. The substance is stable under physiological conditions and is excreted primarily through the kidneys, making it suitable for patients with normal renal function. Gadobutrol is also known for its low osmolality, which reduces the likelihood of discomfort or adverse effects during administration. As with other gadolinium-based agents, there is a risk of nephrogenic systemic fibrosis (NSF) in patients with severe renal impairment, necessitating careful screening before use. Overall, Gadobutrol is valued for its efficacy and safety in enhancing MRI imaging.

Formula: C₁₈H₃₁GdN₄O₉

InChI: InChI=1/C18H34N4O9.Gd/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);/q;+3/p-3/t14-,15-;/s2

InChI key: InChIKey=ZPDFIIGFYAHNSK-ZCTZICQLNA-K

SMILES: O=C1[O-][Gd+3]234567[O-]C(=O)C[N]87CC[N]6(C1)CC[N]5(CC(=O)[O-]2)CC[N]4(CC8)C(CO)C([OH]3)CO

Synonyms:

• (10-((1RS,2SR)-2,3-Dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-))gadolinium
• (SA-8-1425362′5′)-[rel-10-[(2R,3S)-2-(Hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN¹,κN⁴,κN⁷,κN¹⁰,κO¹,κO⁴,κO⁷]gadolinium
• Gadobutrol [INN]
• Gadograf
• Gadolinium, (10-(2,3-Dihydroxy-1-(hydroxymethyl)propyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N1,N4,N7,N10,O1,O4,O7)-
• Gadolinium, [10-[2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN¹,κN⁴,κN⁷,κN¹⁰,κO¹,κO⁴,κO⁷]-, [SA-8-1425362′5′-(R*,S*)]-
• Gadolinium, [rel-10-[(2R,3S)-2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN¹,κN⁴,κN⁷,κN¹⁰,κO¹,κO⁴,κO⁷]-, (SA-8-1425362′5′)-
• Gadovist
• Protovist
• Zk 135079
• gallium 2,2',2''-{10-[(2R,3S)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl}triacetate
• Gadobutrol
• Gadolinium, [rel-10-[(2R,3S)-2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]-, (SA-8-1425362′5′)-
• (SA-8-1425362′5′)-[rel-10-[(2R,3S)-2-(Hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]gadolinium
• Gadolinium, [10-[2-(hydroxy-κO)-3-hydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7]-, [SA-8-1425362′5′-(R*,S*)]-

Gadobutrol

CAS: 138071-82-6

• Formula: C₁₈H₃₁GdN₄O₉
• Molecular weight: 604.72

Gallium 10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-tricarboxylate

CAS: 138071-82-6

• Purity: 98%
• Molecular weight: 475.10699462890625

Gadavist

CAS: 138071-82-6

Gadavist is a gadolinium-based contrast agent that is used in radiology to visualize the brain …

• Formula: C₁₈H₃₁GaN₄O₉
• Purity: Min. 95%
• Molecular weight: 517.2 g/mol